NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Viromed Medical AG's Conversion from Bearer to Registered Shares
TL;DR
Viromed Medical AG's conversion to registered shares offers investors enhanced transparency and direct shareholder communication, potentially improving market positioning and investor relations.
Viromed Medical AG converts bearer shares to registered shares on January 16, 2026, with trading under new ISIN DE000A40ZVN7 beginning January 15, maintaining shareholder rights unchanged.
Viromed Medical AG's transition to registered shares fosters greater corporate transparency and shareholder engagement, supporting ethical investment practices and trust in medical technology innovation.
Viromed Medical AG pioneers cold plasma technology while converting to registered shares, showcasing how medical tech companies adapt financial structures to support growth.
Found this article helpful?
Share it with your network and spread the knowledge!
Viromed Medical AG is converting its share capital from bearer shares to registered shares, following a resolution passed by the Annual General Meeting on July 29, 2025.
The conversion enables increased transparency and direct communication with shareholders, allowing the company to better engage with its investor base.
The depository conversion will occur on the evening of January 16, 2026, with stock exchange trading under the new ISIN beginning on January 15, 2026.
All 21,250,000 bearer shares (ISIN DE000A3MQR65) will be deregistered by custodian banks and Clearstream Banking AG on January 16, 2026, and shareholders will receive one new registered share for each previous bearer share.
The new registered shares will have ISIN DE000A40ZVN7, and they will be listed on the stock exchange under this new identifier starting January 15, 2026.
The conversion does not affect shareholders' percentage of share capital or associated rights, nor does it restrict their ability to sell shares, as registered share transfers don't require company approval.
The existing bearer shares were traded on the stock exchange for the last time on January 14, 2026.
Viromed Medical AG specializes in developing, manufacturing, and distributing medical products, particularly innovative cold plasma technology for medical applications through its subsidiary Viromed Medical GmbH.
For general inquiries, contact Viromed at kontakt@viromed-medical.de, and for press-related questions, contact viromed@kirchhoff.de.
Curated from NewMediaWire
